COMPOUND WITH CONFIDENCE: PCCA Membership, $795/month.

Pharmacy compounding's source for clinical information, regulatory updates, and opportunities

THE PCCA BLOG

rss

Stay current on PCCA news and events, market trends, and all things compounding!

201904_ThePCCABlog_HRTVegas_1768x500.png

PCCA's own Ranel Larsen of Clinical Services gives the low-down on our HRT Symposium. She has lots to say about how compounders use HRT to help patients around the globe. "It is the compounding industry’s biggest hormone replacement event," she says, "And this year was no exception.."

201904_ThePCCABlog_CompoundingAndAutism_1768x500.png

In recognition of National Autism Awareness Month, Tricia Heitman of PCCA's clinical services team, discusses ways in which compounders help families and patients work to manage the obstacles autism presents.

Lipoderm_Still_the_Standard_in_Topical_Pain_Management_Compounding.jpg

The experts in our Clinical Services and Formulation Development departments recommend Lipoderm as a first choice for customized transdermal medications. Here’s why.

201902_ThePCCABlog_WaterActivity_1768x500_Banner.png

Daniel Banov talks about water activity in various products and why they are becoming increasingly important in the pharmacy compounding world.

201902_ThePCCABlog_Tadalafil_1768x500.png

Tadalafil is now free of patents, and compounding pharmacies have some opportunities to use this drug in various customized medications. PCCA's Nat Jones drops in to tell us why that is such exciting news for compounding pharmacies and their patients.

pcca-news2.png

PCCA's own Sebastian Denison to speak on the LDN Radio Show on February 20th, at 3 p.m. CT!

201901_ThePCCABlog_MortarAndPestle_1768x500.png

Mike and Seb had a tremendous January, meeting with industry leaders Dr. Pamela Wartian Smith, Saad Dinno, and Bryan Prescott. You can connect to the best pharmacy compounding podcast on the web right here!

201901_ThePCCABlog_PermE8_1768x500.png

Late last year, we were excited to debut PermE8™ Anhydrous Gel, a new compounding base that holds a lot of potential for compounding pharmacies and their patients, especially when it comes to pain management.

PCCA Blog - 2018 - Azelastine - Main Image 01.png

We’re excited that patients and physicians now have access to Azelastine Hydrochloride USP as an ingredient option in compounded medications. There are some commercial products available, including a combination product, but when those items don’t fit the specific needs of patients, we need to put on our thinking caps and start looking for other options for them. We’re sure that you compounders out there can come up with a few of your own as well.

PCCA Blog - 2018 - PCCA Science Update - Main Image 01.png

By Maria Carvalho, PharmD, MRPharmS, PhD. She is the Manager of PCCA Science.